Could be a real step forward,
Dr Michael Blyth said after the island’s allergy leads submitted a request to the Prescribing Support Unit to get the spray onto the prescribing list, bbc.co.uk reported.
Guernsey health officials are evaluating Eurneffy, a needle-free adrenaline nasal spray designed to treat severe allergic reactions known as anaphylaxis. The medication received approval from the UK medicines regulator in July 2025, but it is not currently available on the island’s local prescribing whitelist, according to bbc.com.
Fear of injections can prevent people from carrying an auto-injector or using it promptly during a reaction, Dr Vicky Carré told bbc.co.uk. She hopes the nasal spray will roll out in Guernsey very soon, though she noted it may not be the right option for everyone.
Henry, 13, who is allergic to many tree nuts, told bbc.com that the spray would be easier for others to use since needles can be quite scary and intimidating. His mother, Anna, said the simple delivery method felt very reassuring.
Another patient, 12-year-old William, who is allergic to wheat and gluten and has an anaphylaxis to dairy, told bbc.com that a nasal spray would be easier and less scary to use because he already uses nasal sprays every day as part of his routine.
The medication must undergo a clinical and financial assessment before a decision is made by the Therapeutics Advisory Group for local use. Dr Blyth told bbc.co.uk that the biggest pitfall is that it is slightly more expensive per device compared with the EpiPen. However, he noted that the nasal spray does have a longer shelf life than EpiPens.
Speaking to bbc.co.uk, Prescribing Support Unit senior pharmacist Marc Jenkins noted that the procedure is designed to guarantee that newly introduced therapies are safe, work well, and make optimal use of available medical funding.
Jenkins pointed out that prior to routine implementation, every drug requires the determination of specific service, monitoring, and prescribing guidelines. Because capacity to undertake clinical assessments can fluctuate, it is not possible to provide a standard timescale for individual applications, according to bbc.com.